Imagine a world where a drug primarily used to deworm horses could hold the key to fighting cancer. It sounds like the plot of a sci-fi novel, but it’s a reality being explored by the U.S. National Cancer Institute (NCI). But here’s where it gets controversial: the NCI, the nation’s leading authority in the battle against cancer, is now studying ivermectin—a drug that has become a lightning rod in the medical and political spheres—as a potential cancer treatment. Could this be a groundbreaking discovery, or is it a misstep fueled by public pressure and political agendas? Let’s dive in.
In a recent statement, NCI Director Anthony Letai, appointed during the Trump administration, revealed that the institute is conducting a preclinical study on ivermectin’s ability to kill cancer cells. ‘There’s enough interest and reports to warrant a closer look,’ Letai explained. But what’s driving this sudden interest? Letai didn’t cite new evidence, leaving many to wonder if this move is scientifically justified or politically motivated.
And this is the part most people miss: while ivermectin is FDA-approved for treating parasitic infections in humans and animals, its effectiveness against cancer remains unproven. Yet, it has become a symbol of resistance against the medical establishment, particularly among adherents of the ‘Make America Healthy Again’ (MAHA) movement and conservative circles. During the COVID-19 pandemic, fringe groups hyped ivermectin as a miracle cure, despite clinical trials proving its ineffectiveness against the virus. Now, the same drug is being touted—without evidence—as a cancer treatment.
This shift has alarmed many career scientists within the NCI. ‘I’m shocked and appalled,’ one anonymous NCI scientist told KFF Health News. ‘We’re diverting funds from promising research to study something based on nonscientific ideas. It’s absurd.’ The concern is not just about the allocation of resources but also the potential harm to patients who might delay proven treatments in favor of unproven alternatives.
The controversy deepens when you consider the political undertones. MAHA supporters and some conservative commentators claim that ivermectin and other off-patent drugs are suppressed by the government and pharmaceutical companies because they’re not profitable. Robert F. Kennedy Jr., a vocal supporter of the MAHA movement, recently declared on X, ‘FDA’s war on public health is about to end,’ accusing the agency of suppressing ivermectin and other therapies. But is this a legitimate critique or a conspiracy theory?
Here’s the kicker: while some laboratory studies suggest ivermectin could have anticancer effects by promoting cell death and inhibiting tumor growth, there’s no evidence it’s safe or effective in humans. A small clinical trial combining ivermectin with immunotherapy for metastatic breast cancer found no significant benefit. Yet, celebrities like Mel Gibson and online influencers continue to promote it as a cure-all, reaching millions with unverified claims.
This raises a critical question: Should scientific institutions like the NCI prioritize public interest, even when it’s driven by misinformation, or focus solely on evidence-based research? NIH Director Jay Bhattacharya argues, ‘If lots of people believe it and it’s moving public health, we have an obligation to take it seriously.’ But at what cost?
The debate doesn’t end there. Some states, like Florida, are funding research into ivermectin as a cancer treatment, further blurring the line between science and politics. Meanwhile, physicians like Jeffery Edenfield of Prisma Health Cancer Institute warn that patients are increasingly turning to ivermectin based on social media claims, sometimes forgoing proven therapies. ‘We’re in a delicate time of mistrust in medicine,’ Edenfield notes. ‘Some people just won’t believe me, but I have to keep trying.’
So, what do you think? Is the NCI’s study a necessary step in exploring all potential treatments, or is it a dangerous diversion of resources? Should public opinion influence scientific research, even when it’s rooted in misinformation? Let’s keep the conversation going—share your thoughts in the comments below.
